|
Originally published In Press as doi:10.1074/jbc.M207700200 on January 9, 2003
J. Biol. Chem., Vol. 278, Issue 11, 9862-9868, March 14, 2003
Protection of Islets by in Situ
Peptide-mediated Transduction of the I B Kinase Inhibitor
Nemo-binding Domain Peptide*
Khaja K.
Rehman ,
Suzanne
Bertera§,
Rita
Bottino§,
A. N.
Balamurugan§,
Jeffrey
C.
Mai ,
Zhibao
Mi ,
Massimo
Trucco§, and
Paul D.
Robbins ¶
From the Department of Molecular Genetics and
Biochemistry, University of Pittsburgh School of Medicine,
Pittsburgh, Pennsylvania 15261 and the § Department of
Pediatrics, University of Pittsburgh School of Medicine,
Pittsburgh, Pennsylvania 15261
We have previously demonstrated that adenoviral
gene transfer of the NF- B inhibitor I B to human islets results in
protection from interleukin (IL)-1 -mediated dysfunction and
apoptosis. Here we report that human and mouse islets can be
efficiently transduced by a cationic peptide transduction domain
(PTD-5) without impairment of islet function. PTD mediated delivery of
a peptide inhibitor of the IL-1 -induced I B kinase (IKK), derived
from IKK (NBD; Nemo-binding domain), and completely blocked the
detrimental effects of IL-1 on islet function and NF- B activity,
in a similar manner to Ad-I B. We also demonstrate that mouse islets
can be transduced in situ by infusion of the transduction
peptide through the bile duct prior to isolation, resulting in 40%
peptide transduction of the -cells. Delivery of the IKK inhibitor
transduction fusion peptide (PTD-5-NBD) in situ
to mouse islets resulted in improved islet function and viability after
isolation. These results demonstrate the feasibility of using
PTD-mediated delivery to transiently modify islets in situ
to improve their viability and function during isolation, prior to transplantation.
*
This work was supported by a grants from the Juvenile
Diabetes Research Foundation, the Muscular Dystrophy
Association, and National Institutes of Health Contract
AR-6-2225.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom all correspondence should be addressed: Dept. of
Molecular Genetics and Biochemistry, University of Pittsburgh, School of Medicine, W1246, Biomedical Science Tower, Pittsburgh, PA 15261. Tel.: 412-648-9268; Fax: 412-383-8837; E-mail: probb@pitt.edu.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. H. Dave, J. S. Tilstra, K. Matsuoka, F. Li, T. Karrasch, J. K. Uno, A. R. Sepulveda, C. Jobin, A. S. Baldwin, P. D. Robbins, et al.
Amelioration of Chronic Murine Colitis by Peptide-Mediated Transduction of the I{kappa}B Kinase Inhibitor NEMO Binding Domain Peptide
J. Immunol.,
December 1, 2007;
179(11):
7852 - 7859.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Wang, T. Zhu, K. K. Rehman, S. Bertera, J. Zhang, C. Chen, G. Papworth, S. Watkins, M. Trucco, P. D. Robbins, et al.
Widespread and Stable Pancreatic Gene Transfer by Adeno-Associated Virus Vectors via Different Routes.
Diabetes,
April 1, 2006;
55(4):
875 - 884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S K Richards, L E Parton, I Leclerc, G A Rutter, and R M Smith
Over-expression of AMP-activated protein kinase impairs pancreatic {beta}-cell function in vivo
J. Endocrinol.,
November 1, 2005;
187(2):
225 - 235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Hammar, J.-C. Irminger, K. Rickenbach, G. Parnaud, P. Ribaux, D. Bosco, D. G. Rouiller, and P. A. Halban
Activation of NF-{kappa}B by Extracellular Matrix Is Involved in Spreading and Glucose-stimulated Insulin Secretion of Pancreatic Beta Cells
J. Biol. Chem.,
August 26, 2005;
280(34):
30630 - 30637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Samli, M. J. McGuire, C. B. Newgard, S. A. Johnston, and K. C. Brown
Peptide-Mediated Targeting of the Islets of Langerhans
Diabetes,
July 1, 2005;
54(7):
2103 - 2108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhou, X.-P. Gao, J. Fan, Q. Liu, K. N. Anwar, R. S. Frey, and A. B. Malik
LPS activation of Toll-like receptor 4 signals CD11b/CD18 expression in neutrophils
Am J Physiol Lung Cell Mol Physiol,
April 1, 2005;
288(4):
L655 - L662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Abdelli, J. Ansite, R. Roduit, T. Borsello, I. Matsumoto, T. Sawada, N. Allaman-Pillet, H. Henry, J. S. Beckmann, B. J. Hering, et al.
Intracellular Stress Signaling Pathways Activated During Human Islet Preparation and Following Acute Cytokine Exposure
Diabetes,
November 1, 2004;
53(11):
2815 - 2823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Zeender, K. Maedler, D. Bosco, T. Berney, M. Y. Donath, and P. A. Halban
Pioglitazone and Sodium Salicylate Protect Human {beta}-Cells against Apoptosis and Impaired Function Induced by Glucose and Interleukin-1{beta}
J. Clin. Endocrinol. Metab.,
October 1, 2004;
89(10):
5059 - 5066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Zhang, A. Richter, J. Suriawinata, S. Harbaran, J. Altomonte, L. Cong, H. Zhang, K. Song, M. Meseck, J. Bromberg, et al.
Elevated Vascular Endothelial Growth Factor Production in Islets Improves Islet Graft Vascularization
Diabetes,
April 1, 2004;
53(4):
963 - 970.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|